tiprankstipranks
Percheron Therapeutics (PERCF)
OTHER OTC:PERCF
US Market
PERCF
Percheron Therapeutics
RESEARCH TOOLSreports

Percheron Therapeutics (PERCF) Ratios

13 Followers

Percheron Therapeutics Ratios

PERCF's free cash flow for Q4 2026 was AU$0.00. For the 2026 fiscal year, PERCF's free cash flow was decreased by AU$ and operating cash flow was AU$0.00. See a summary of the company’s cash flow.
Ratios
TTM
Jun 26Jun 25Jun 24Jun 23
Liquidity Ratios
Current Ratio
 7.64 7.64 5.10 2.81 4.51
Quick Ratio
 7.64 7.64 5.10 2.81 4.51
Cash Ratio
 3.69 3.69 4.18 2.30 3.90
Solvency Ratio
 -6.61 -6.61 -6.11 -2.29 -3.94
Operating Cash Flow Ratio
 -7.17 -7.17 -6.43 -1.96 -2.90
Short-Term Operating Cash Flow Coverage
 -178.55 -178.55 0.00 -253.70 -86.64
Net Current Asset Value
AU$ 4.59MAU$ 4.59MAU$ 9.97MAU$ 9.31MAU$ 9.82M
Leverage Ratios
Debt-to-Assets Ratio
 <0.01 <0.01 <0.01 <0.01 0.01
Debt-to-Equity Ratio
 <0.01 <0.01 <0.01 <0.01 0.01
Debt-to-Capital Ratio
 <0.01 <0.01 <0.01 <0.01 0.01
Long-Term Debt-to-Capital Ratio
 0.00 0.00 0.00 0.00 0.00
Financial Leverage Ratio
 1.09 1.09 1.24 1.55 1.29
Debt Service Coverage Ratio
 -109.08 -109.08 -993.77 -218.14 -114.15
Interest Coverage Ratio
 -366.34 -366.34 -1.12K -4.13K -1.64K
Debt to Market Cap
 <0.01 <0.01 0.00 <0.01 <0.01
Interest Debt Per Share
 <0.01 <0.01 <0.01 <0.01 <0.01
Net Debt to EBITDA
 0.47 0.47 0.62 1.00 0.82
Profitability Margins
Gross Profit Margin
0.00%0.00%0.00%0.00%0.00%
EBIT Margin
0.00%0.00%0.00%0.00%0.00%
EBITDA Margin
0.00%0.00%0.00%0.00%0.00%
Operating Profit Margin
0.00%0.00%0.00%0.00%0.00%
Pretax Profit Margin
0.00%0.00%0.00%0.00%0.00%
Net Profit Margin
0.00%0.00%0.00%0.00%0.00%
Continuous Operations Profit Margin
0.00%0.00%0.00%0.00%0.00%
Net Income Per EBT
87.31%87.31%91.26%83.52%87.81%
EBT Per EBIT
97.65%97.65%97.87%95.91%97.11%
Return on Assets (ROA)
-58.27%-58.27%-119.99%-82.03%-88.61%
Return on Equity (ROE)
-65.33%-63.63%-149.16%-127.30%-114.08%
Return on Capital Employed (ROCE)
-74.63%-74.63%-167.02%-158.67%-133.04%
Return on Invested Capital (ROIC)
-64.92%-64.92%-152.02%-131.40%-114.67%
Return on Tangible Assets
-90.00%-90.00%-119.99%-82.03%-88.61%
Earnings Yield
-87.33%-136.17%-145.71%-22.27%-28.83%
Efficiency Ratios
Receivables Turnover
 0.00 0.00 0.00 0.00 0.00
Payables Turnover
 0.45 1.20 0.05 0.02 0.09
Inventory Turnover
 0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover
 0.00 0.00 0.00 0.00 0.00
Asset Turnover
 0.00 0.00 0.00 0.00 0.00
Working Capital Turnover Ratio
 0.00 0.00 0.00 0.00 0.00
Cash Conversion Cycle
 -815.69 -303.66 -7.68K -17.13K -3.92K
Days of Sales Outstanding
 0.00 0.00 0.00 0.00 0.00
Days of Inventory Outstanding
 0.00 0.00 0.00 0.00 0.00
Days of Payables Outstanding
 815.69 303.66 7.68K 17.13K 3.92K
Operating Cycle
 0.00 0.00 0.00 0.00 0.00
Cash Flow Ratios
Operating Cash Flow Per Share
 >-0.01 >-0.01 -0.02 -0.02 -0.01
Free Cash Flow Per Share
 >-0.01 >-0.01 -0.02 -0.02 -0.01
CapEx Per Share
 <0.01 <0.01 <0.01 <0.01 <0.01
Free Cash Flow to Operating Cash Flow
 1.00 1.00 1.00 1.00 1.00
Dividend Paid and CapEx Coverage Ratio
 -624.43 -625.22 -2.16K -2.81K -278.29
Capital Expenditure Coverage Ratio
 -624.43 -625.22 -2.16K -2.81K -278.29
Operating Cash Flow Coverage Ratio
 -178.55 -178.55 -604.81 -253.70 -57.36
Operating Cash Flow to Sales Ratio
 0.00 0.00 0.00 0.00 0.00
Free Cash Flow Yield
-111.51%-141.21%-152.82%-18.91%-20.72%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 -0.98 -0.73 -0.68 -4.49 -3.47
Price-to-Sales (P/S) Ratio
 0.00 0.00 0.00 0.00 0.00
Price-to-Book (P/B) Ratio
 0.73 0.47 1.02 5.72 3.96
Price-to-Free Cash Flow (P/FCF) Ratio
 -0.90 -0.71 -0.65 -5.29 -4.83
Price-to-Operating Cash Flow Ratio
 -1.11 -0.71 -0.65 -5.29 -4.84
Price-to-Earnings Growth (PEG) Ratio
 >-0.01 0.01 0.04 -0.95 -0.04
Price-to-Fair Value
 0.73 0.47 1.02 5.72 3.96
Enterprise Value Multiple
 -0.36 -0.18 >-0.01 -3.52 -2.16
Enterprise Value
 1.93M 994.40K 98.96K 41.70M 28.65M
EV to EBITDA
 -0.36 -0.18 >-0.01 -3.52 -2.16
EV to Sales
 0.00 0.00 0.00 0.00 0.00
EV to Free Cash Flow
 -0.39 -0.20 >-0.01 -4.12 -3.50
EV to Operating Cash Flow
 -0.39 -0.20 >-0.01 -4.12 -3.51
Tangible Book Value Per Share
 <0.01 <0.01 <0.01 0.01 0.01
Shareholders’ Equity Per Share
 <0.01 <0.01 <0.01 0.01 0.01
Tax and Other Ratios
Effective Tax Rate
 0.13 0.13 0.09 0.16 0.12
Revenue Per Share
 0.00 0.00 0.00 0.00 0.00
Net Income Per Share
 >-0.01 >-0.01 -0.01 -0.02 -0.02
Tax Burden
 0.87 0.87 0.91 0.84 0.88
Interest Burden
 0.98 0.98 1.00 1.20 0.97
Research & Development to Revenue
 0.00 0.00 0.00 0.00 0.00
SG&A to Revenue
 0.00 0.00 0.00 0.00 0.00
Stock-Based Compensation to Revenue
 0.00 0.00 0.00 0.00 0.00
Income Quality
 1.04 1.04 1.05 0.85 0.72
Currency in AUD